Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Recht

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 22, 2017
Prevalence and impact of obesity in people with haemophilia: Review of literature and expert discussion around implementing weight management guidelinesS Kahan, A Cuker, R F Kushner, et al.
Radiology|April 1, 1993
Blood flow in the portal vein: velocity quantitation with phase-contrast MR angiographyG R Applegate, F L Thaete, S P Meyers, et al.
The EMBO Journal|June 10, 1998
Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathwayM Rincón, H Enslen, J Raingeaud, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 1, 2017
Unexpected pharmacokinetics of recombinant porcine factor VIII in a patient with acquired factor VIII deficiency and spontaneous epidural haematomaJ J Shatzel, S Azar, R Scherber, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 21, 2009
Experience with a third generation recombinant factor VIII concentrate (Advate) for immune tolerance induction in patients with haemophilia AL A Valentino, M Recht, J Dipaola, et al.
Osteoarthritis and Cartilage|July 10, 2012
A new method to analyze dGEMRIC measurements in femoroacetabular impingement: preliminary validation against arthroscopic findingsR Lattanzi, C Petchprapa, C Glaser, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 8, 2018
Goal Attainment Scaling for haemophilia (GAS-Hēm): testing the feasibility of a new patient-centric outcome measure in people with haemophiliaJ C Roberts, S Lattimore, M Recht, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 9, 2017
Impact of pain and functional impairment in US adults with haemophilia: Patient-reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P-FiQ) studyC L Kempton, M Recht, A Neff, et al.
Journal of Thrombosis and Haemostasis : JTH|September 13, 2015
Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicityJ N Mahlangu, K N Weldingh, S R Lentz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 8, 2013
Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacyS R Lentz, M Misgav, M Ozelo, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 22, 2017
Prevalence and impact of obesity in people with haemophilia: Review of literature and expert discussion around implementing weight management guidelinesS Kahan, A Cuker, R F Kushner, et al.
Radiology|April 1, 1993
Blood flow in the portal vein: velocity quantitation with phase-contrast MR angiographyG R Applegate, F L Thaete, S P Meyers, et al.
The EMBO Journal|June 10, 1998
Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathwayM Rincón, H Enslen, J Raingeaud, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 1, 2017
Unexpected pharmacokinetics of recombinant porcine factor VIII in a patient with acquired factor VIII deficiency and spontaneous epidural haematomaJ J Shatzel, S Azar, R Scherber, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 21, 2009
Experience with a third generation recombinant factor VIII concentrate (Advate) for immune tolerance induction in patients with haemophilia AL A Valentino, M Recht, J Dipaola, et al.
Osteoarthritis and Cartilage|July 10, 2012
A new method to analyze dGEMRIC measurements in femoroacetabular impingement: preliminary validation against arthroscopic findingsR Lattanzi, C Petchprapa, C Glaser, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 8, 2018
Goal Attainment Scaling for haemophilia (GAS-Hēm): testing the feasibility of a new patient-centric outcome measure in people with haemophiliaJ C Roberts, S Lattimore, M Recht, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 9, 2017
Impact of pain and functional impairment in US adults with haemophilia: Patient-reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P-FiQ) studyC L Kempton, M Recht, A Neff, et al.
Journal of Thrombosis and Haemostasis : JTH|September 13, 2015
Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicityJ N Mahlangu, K N Weldingh, S R Lentz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 8, 2013
Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacyS R Lentz, M Misgav, M Ozelo, et al.
Pageof 5